IoversolMarket - Global Industry Insights, Size, Share, Trends, Outlook, and OpportunityAnalysis, 2018-2026
Ioversol is a white to off-whitecrystalline powder having a crystalline sulfide-like odor. It is a non-ionicradiological contrast agent that is included in a group of drugs known asradiopaque contrast agents. It contains iodine, a substance that has theability to absorb x-rays. Ioversol allows the blood vessels, organs and othersnon-bony tissues of the body to be seen more clearly during a CT scan or similarradiologic (x-ray) examination. Ioversol is injected into an artery or veinthrough an IV (Intravenous). The uniqueness and versatility of ioversol hasalso expanded its use in magnetic resonance imaging and ultrasound scattering.Ioversol is also used for the treatment, control, prevention and improvement ofheart disorders, brain disorders and blood vessel disorders. Ioversol isgenerally not given on dosage. However, in some cases, a dosage of ioversol isgiven to the patient based on the condition he/she is being treated, howpatient respond to this drug, patient’s weight, height, age, and gender, etc.CMI predicts the global Ioversal market to grow at a healthy growth rate overthe forecast period owing to an escalating demand for ioversol among consumersand clinics.
* The sample copy includes: Report Summary, Table ofContents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/386
The market for ioversol is mainlydriven by the robustly growing imaging and x-ray market. Rising prevalence ofcardiovascular disorders is giving pace to x-ray industry and thus the ioversolmarket. Bone-related challenges and diseases, rising accidents and kidneyrelated problems are the key drivers for growth of the ioversol industry.Another factor boosting growth of the global ioversol market is the growinggeriatric population which are more prone to orthopedic disorders than theyounger demographics. However, factors such as allergic reaction by use ofioversol, swelling, difficulty in breathing, rapid weight gain, joint pain orstiffness, muscle pain or weakness, nausea, sweating, etc. may hamper thedemand for ioversol in the near future. Advancements in the computed tomography(CT) technology can prove to be a lucrative factor for market growth over theforecast period.
Ioversol 64% Injectable Solution,made from 636 mg of ioversol with 3.6 mg of tromethamine as a buffer and 0.2 mgof calcium disodium as a stabilizer, is the most commonly used ioversol typeprimarily owing to high scope of application, ease of use and low cost. On thebasis of application, the x-ray segment is forecast to grow at the fastest rateover the forecast period owing to the growing demand for ioversol inangiography, tomography, urography and others.
Market Outlook - Asia Pacific isexpected to be the most lucrative region for the key players operating in theglobal Ioversol market
Browse ResearchReport: https://www.coherentmarketinsights.com/ongoing-insight/ioversol-market-386
On the basis of geography, theglobal ioversol market is segmented into North America, Latin America, Europe,Middle East, Asia-Pacific and Africa. Market of Ioversol is anticipated towitness a high demand in the Asia-Pacific region owing to the constant rise inpharmaceutical spending, increasing awareness regarding the use of ioversol andthe growing population base, particularly in countries such as China and India.North America is currently the second largest market for ioversol and isexpected to grow at an above average growth rate over the forecast period.Europe is expected to showcase a sluggish growth during the forecast periodowing to the maturing pharmaceutical industry.
The key players profiled in theglobal ioversol market are Liebel-Flarsheim Company LLC, Guerbet, JiangsuHengrui Medicine Co., Mallinckrodt Pharmaceuticals, Ultraject, China ResourcesPharmaceutical Co., HB Ocean, Changzhou Highassay Chemical Co., Ltd., andvarious others. Major players in the market are focused on product launches andorganic growth by means of mergers and acquisitions.
Buy-Now this researchreport: https://www.coherentmarketinsights.com/insight/buy-now/386
AboutCoherent Market Insights:
CoherentMarket Insights is a prominent market research and consulting firm offeringaction-ready syndicated research reports, custom market analysis, consultingservices, and competitive analysis through various recommendations related toemerging market trends, technologies, and potential absolute dollaropportunity.
ContactUs:
mailto:sales@coherentmarketinsights.com
U.S.Office:
Name: Mr. Shah
CoherentMarket Insights 1001 4th Ave,
# 3200Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
